Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MedAdvisor Limited ( (AU:MDR) ) just unveiled an update.
MedAdvisor Limited announced an addendum to its Quarterly Activities Report for the fourth quarter of FY25, highlighting a payment of A$437k to related parties that was omitted from the initial report. This disclosure ensures transparency in financial reporting and may impact stakeholder trust and compliance with ASX regulations.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.21 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Solutions is a leader in pharmacy-driven patient engagement solutions, providing personalized experiences to simplify the medication journey. Utilizing THRiV, a cloud-based, AI-enabled platform, the company enhances pharmacy workflows and patient engagement, collaborating with over 34,000 pharmacies across the US, reaching over two-thirds of the population.
Average Trading Volume: 1,174,607
Technical Sentiment Signal: Sell
Current Market Cap: A$43.77M
For a thorough assessment of MDR stock, go to TipRanks’ Stock Analysis page.